Welcome to the e-CCO Library Archive!

Filter:
P089

Disease course, phenotype, and medication use in elderly-onset Crohn's disease patients - A population-based IBD-SL cohort study

Authors:

S. Jeuring*1, 2, T. Van den Heuvel1, 2, M. Zeegers3, 4, W. Hameeteman1, M. Romberg-Camps5, L. Oostenbrug6, A. Masclee1, 2, D. Jonkers1, 2, M. Pierik1, 2

1Maastricht University Medical Center+, Internal Medicine - Division Gastroenterology-Hepatology, Maastricht, Netherlands, 2Maastricht University Medical Center+, NUTRIM, School for Nutrition, Toxicology and Metabolism, Maastricht, Netherlands, 3University of Birmingham, Public Health, Epidemiology and Biostatistics, Birmingham, United Kingdom, 4Maastricht University Medical Center+, Complex Genetics, Cluster of Genetics and Cell Biology, Maastricht, Netherlands, 5Orbis Medical Center, Gastroenterology and Hepatology, Sittard, Netherlands, 6Atrium Medical Center, Internal Medicine and Gastroenterology, Heerlen, Netherlands

P090.

Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action

Authors:

V. Petito1, L. Lopetuso1, E. Stigliano2, V. Arena2, S. Bibbo1, A. Amato3, G. Cammarota1, A. Papa1,4, A. Sgambato2, A. Gasbarrini1, F. Scaldaferri1, 1Catholic University of Sacred Heart, Internal Medicine and Gastroenterology, Rome, Italy, 2Catholic University of Sacred Heart, Pathology, Rome, Italy, 3Catholic University of Sacred Heart, Anesthesiology, Rome, Italy, 4Catholic Universisty, Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Rome, Italy

P090. Differential effects of sulphasalazine, azathioprine and prednisolone on the MAP-kinases gene expression in the TNBS-induced intestinal inflammation
Authors:

A. Quaglio1, A. Castilho1, L. Di Stasi1, 1Universidade Estadual Paulista (UNESP), Pharmacology, Botucatu, Brazil

P090. Prospective controlled analysis of vitamin B12 and folate deficiency in Crohn's disease
P090. Restoration of health in patients with inflammatory bowel disease and mucosal healing
P090

Evaluation of NT-proBNP in Inflammatory Bowel Disease

Authors:

A. Wacrenier*1, A.-M. Bourgeois2, J. Ausseil2, C. Szymanski3, H. Thiebault1, F. Brazier1, A. Galmiche2, E. Nguyen-Khac1, J.-L. Dupas1, J.-f. Colombel4, M. Fumery1

1Amiens University Hospital, Hepatogastroenterology, Amiens, France, 2Amiens University Hospital, Biochimie, Amiens, France, 3Amiens University Hospital, Cardiology, Amiens, France, 4Icahn School of Medicine at Mount Sinai Hospital, Gastroenterology, New York, NY, United States

P091.

Controlling the balance of immunity in colitis: Investigating the roles of intestinal microbiota and dendritic cell migration

Authors:

S. Borg-Bartolo1, J. McLaughlin2, C. Ballestrem3, S. Cruickshank1, 1University of Manchester, Manchester Immunology Group, Faculty of Life Sciences, Manchester, United Kingdom, 2Salford Royal NHS Foundation Trust, School of Translational Medicine, Manchester, United Kingdom, 3University of Manchester, Wellcome Trust Centre for Cell Matrix Research, Manchester, United Kingdom

P091. Development of a patient-reported outcome measure for Crohn's disease
Authors:

J. Wilburn1, S.P. McKenna1, J. Twiss1, M. Ben-L'amri1, K. Kemp2, S. Campbell2, 1Galen Research Ltd, Manchester Science Park, Manchester, United Kingdom, 2Central Manchester University Hospitals NHS Foundation Trust, Gastroenterology, Manchester, United Kingdom

P091. Longstanding ulcerative colitis related dysplasia – COX-2 and ultrastructural correlations
P091. The detection of Clostridium difficile toxin A + B in inflammatory bowel disease on the background of immunosuppressive therapy
P091

The impact of a value-based health program for inflammatory bowel disease management on healthcare utilization

Authors:

W.K. van Deen*1, A.B. Ozbay2, M. Skup2, M.G. van Oijen1, A. Centeno1, N. Duran1, P. Lacey1, D. Jatulis3, M. Belman3, E. Esrailian1, D.W. Hommes1

1UCLA Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, University of California, Los Angeles, Los Angeles, United States, 2AbbVie, US Immunology, Nort Chicago, United States, 3Anthem Blue Cross, California, Woodland Hills, United States

P092.

Co-administration of 5-aminosalicylic acid to 6-mercaptopurine reduces in vitro hepatotoxicity

Authors:

M. Broekman, H.M. Roelofs, F. Hoentjen, M. Kerstholt, W.H. Peters, G.J. Wanten, D.J. de Jong, Radboud UMC, Gastroenterology & Hepatology, Nijmegen, Netherlands

P092. Detection of apoptosis in intestinal mucosa and mesenteric fat tissue of Crohn's disease
Authors:

C.B. Dias1, L.R. Meirelles2, M. Milanski3, M.L.S. Ayrizono4, A. Coope3, M. Portovedo3, N. Planell5, C.S.R. Coy4, L.A. Velloso3, R.F. Leal1, 1University of Campinas, Colorectal Surgery Unit, Surgery Department. Cell Signalization Laboratory, Internal Medicine Department, Campinas, Brazil, 2University of Campinas, Pathology Department, Campinas, Brazil, 3University of Campinas, Cell Signalization Laboratory, Internal Medicine Department, Campinas, Brazil, 4University of Campinas, Colorectal Surgery Unit, Surgery Department, Campinas, Brazil, 5CIBER-EHD, Department of Gastroenterology and Bioinformatics Platform, Barcelona, Spain

P092. Developing a short form Crohn's and Colitis Questionnaire (CCQ) for patients with inflammatory bowel disease
P092. Usefulness of faecal calprotectin to detect postoperative endoscopic recurrence in Crohn's disease
P092

Risk factors for active tuberculosis in patients with inflammatory bowel disease: A case-control study

Authors:

S. Riestra1, R. de Francisco*2, M. Arias-Guillén3, C. Saro4, M. García-Alvarado5, J.M. Duque6, L. Blanco2, O. Castaño2, F. Muñoz5, I. Pérez-Martínez2, P. Martínez-Camblor7, D. Pérez-Hernández8

1Hospital Universitario Central de Asturias , Gastroenterology, Oviedo, Spain, 2Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain, 3Hospital Universitario Central de Asturias, Respiratory, Oviedo, Spain, 4Hospital de Cabueñes, Gastroenterology, Gijón, Spain, 5Hospital de León, Gastroenterology, León, Spain, 6Hospital San Agustín, Gastroenterology, Avilés, Spain, 7Hospital Universitario Central de Asturias, Oficina de Investigación Biosanitaria, Oviedo, Spain, 8Consejería de Salud, Servicio de Vigilancia Epidemiológica, Oviedo, Spain

P093.

Circulating microvesicles in Crohn's disease

Authors:

E. Gaetani, M. Marcantoni, I. Giarretta, I. Gatto, F. Scaldaferri, F. Del Zompo, L. Laterza, A. Tortora, R. Landi, A. Gasbarrini, R. Pola, Catholic University of Sacred Heart, Internal Medicine and Gastroenterology, Rome, Italy

P093. Dendritic cell characteristics in pouchitis
Authors:

J. Landy1, E. Ronde2, H. Omar Al-Hassi2, E. Mann2, S. Peake1, P.J. Ciclitira3, R.J. Nicholls4, S.K. Clark5, S. Knight2, A.L. Hart1, 1St Mark's Hospital, IBD Unit, London, United Kingdom, 2Antigen Presentation Research Group, Imperial College, London, United Kingdom, 3St Thomas' Hospital, Gastroenterology, London, United Kingdom, 4Imperial College, Department of Biosurgery and Surgical Technology, London, United Kingdom, 5St Mark's Hospital, Colorectal Surgery, London, United Kingdom

P093. Impact of magnetic resonance enterography in the management of small bowel Crohn's disease
P093. Preparation for colonoscopy in everyday routine – what makes it successful?